| Document Date: 2014-08-11 16:01:04
Open Document File Size: 258,94 KBShare Result on Facebook
Company Dendreon / Sandia National Laboratories / Oncothyreon / Brookside Capital Partners / Ayer Capital Management / Bain Capital / Alpine BioSciences / / Currency USD / / Event M&A / / Facility University of New Mexico / / IndustryTerm clinical stage products / biotechnology / protocell technology / chemical and nuclear engineering / transformative technology / / MedicalCondition cancer / genetic diseases / individual prostate cancer / / MedicalTreatment immunotherapy / / NaturalFeature Alpine / / Organization U.S. Department of Energy / FDA / University of New Mexico / / Person Ray Kurzweil / Jeff Brinker / Jay Venkatesan / Robert Kirkman / Mitchell H Gold / Christopher Henney / / Position CEO / president and CEO / co-founder / professor of chemical and nuclear engineering / chairman of the board / / ProvinceOrState New Mexico / / Technology siRNA / biotechnology / potentially transformative technology / protocell technology / /
SocialTag |
Solving the ‘Impossible’ with Science By Mitchell H Gold M.D. August 11, 2014 After spending almost a decade as CEO of Dendreon developing the world’s first immunotherapy, and shepherding Provenge through FDA appro